Animal Diagnostic Kit Market Size, Share, Growth, and Industry Analysis, By Type (Antigen Testing, Antibody Testing, Nucleic acid Amplification Testing, and Others), By Application (Pet Hospital, and Home Use), and Regional Forecast to 2032

ANIMAL DIAGNOSTIC KIT MARKET OVERVIEW

The global Animal Diagnostic Kit market size was USD  1.10 billion in 2024 and is projected to touch USD 2.37 billion by 2032, exhibiting a CAGR of 7.96% during the forecast period.

Animal diagnostic kit is a rapidly developing sector fueled by the need for increasing accuracy and efficiency in diagnosing the disease to achieve animal health. This market involves diagnostic kits and tools that help diagnose disease in animals, ranging from livestock, pets, to wild animals. Major driving factors of this growth include the rising disease burden due to zoonotic diseases, the development of animal health consciousness among the people, rapid progresses in diagnostic technologies, as well as increasing adoption of companions. Other government efforts that contribute to veterinary care policy along with the growing stock farming add to market growth. Innovations are experienced by the market due to point-of-care testing molecular diagnostics and biosensors by offering quicker and more sensitive results.

GLOBAL CRISES IMPACTING ANIMAL DIAGNOSTIC KIT MARKETCOVID-19 IMPACT

Animal Diagnostic Kit Industry Had a Negative Effect Due to supply chain disruptions during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The impact of COVID-19 was both significant and multifaceted on the animal diagnostic kit market, though its effects were generally lesser than expected in some cases. Concerns about disruptions in the supply chain and labor shortages as well as reduced veterinary visits at the onset of the pandemic made it seem like a potential downward trend in market activity would be witnessed. However, these impacts were mitigated by the essential nature of veterinary services and the increasing focus on zoonotic disease surveillance during the pandemic.

Demand for animal diagnostic kits was relatively stable, if not increasing, in certain segments, such as livestock health monitoring, as governments and organizations invested in food security and animal health. Secondly, there was heightened interest in the interconnection between human and animal health, commonly known as the One Health approach, leading to investments in diagnostics and disease prevention. In that regard, early logistical challenges were overcome by advancements in technology, remote veterinary consultation, and point-of-care diagnostic solutions.

LATEST TREND

Increasing adoption of point-of-care (POC) diagnostic solutions to Drive Market Growth

Among these various trends, the increased use of point-of-care (POC) diagnostic solutions stands notable in the animal diagnostic kit market. These easy, portable, and user-friendly devices allow veterinarians the ability to conduct an instantaneous test during consultation hours-thus leading to quick resolution and better care of their animals. This can mainly be attributed to advances through technology that have further sharpened the accuracy and efficacy of POC diagnostics hence making them indispensable for all in veterinary practice. The convenience and efficiency offered by the kits are reshaping animal diagnostics, emphasizing rapid capabilities to test on-site.

ANIMAL DIAGNOSTIC KIT MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into Antigen Testing, Antibody Testing, Nucleic acid Amplification Testing, and Others

• Antigen Testing: This requires the detection of specific antigens to diagnose infections or diseases in animals, making it fast and reliable for results.
• Antibody Testing: Identifies the presence of antibodies in animal samples that expose them to certain pathogens or vaccines.
• Nucleic Acid Amplification Testing: This testing technique utilizes techniques such as PCR to recognize genetic material from pathogens for high sensitivity and specificity.
• Others: It has several diagnostics, including biosensors, imaging-based diagnostics, and emerging technologies targeted towards niche applications.
  
  

BY APPLICATION

Based on application, the global market can be categorized into Pet Hospital, and Home Use

• Pet Hospitals: These kits have widely been used in veterinary hospitals and clinics for the disease diagnosis of pets, providing the correct treatment and care.
• Home Use: Diagnostic kits which are used at home have the advantage of monitoring an animal's health conveniently, providing the owner with early disease diagnosis and minimizing the frequent trips to the hospital.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.     

DRIVING FACTORS

Increasing Prevalence of Zoonotic Diseases to Boost the Market

Increased prevalence of zoonotic diseases is an important driver for the market for animal diagnostic kits. A spate of high-profile outbreaks, such as avian influenza, swine flu, and rabies, clearly points to the fact that early and accurate diagnosis helps control such diseases. Governments and other bodies across the world are keen on implementing measures for surveillance and control of zoonotic diseases, thus upping the demand for more sophisticated diagnostic tools.

Technological advancements in veterinary diagnostics to Expand the Market

Diagnostic technology innovations, such as PCR-based nucleic acid amplification tests, biosensors, and point-of-care testing devices, are boosting market growth. These innovations offer veterinarians and pet owners quicker, more accurate, and accessible testing options, leading to increased adoption of diagnostic kits in both clinical and home-use applications.

RESTRAINING FACTOR

High costs of diagnostic kits and equipment to Potentially Impede Market Growth

The main barrier is cost in relation to advanced diagnostic kits and equipment, mostly for developing economies. Vet clinics and pet owners face challenges investing in high-cost diagnostic solutions, which, therefore limits market penetration in those areas. Moreover, the costs of maintenance are an additional challenge, which calls for highly skilled manpower to handle complex diagnostic machinery.

OPPORTUNITY

Increased Pet Ownership and Anthropomorphization of Animals To Create Opportunity for the Product in the Market

It becomes an extremely lucrative opportunity as pet ownership is increasing as well as the humanizing of pets. The better care that pet owners tend to seek for their companion animals by investing in health services means premium health checkups and advanced diagnostics and diagnostic kits, making demands user-friendly and reliable as they relate to companion animals.

CHALLENGE

Strict Regulatory Frameworks Could Be a Potential Challenge for Consumers

The animal diagnostic kit market faces challenges due to strict regulatory requirements and long approval periods for new diagnostic products. Manufacturers are subjected to rigid standards for product safety, efficacy, and reliability. These regulations may delay product launches and raise the cost of development, thus challenging small companies and new entrants.

ANIMAL DIAGNOSTIC KIT MARKET REGIONAL INSIGHTS

Request a Free sample to learn more about this report.

• North America

North America is dominating due to its superior veterinary health care infrastructure, a strong pet ownership rate, and rising adoption of advanced diagnostic innovations. The region also includes key market players and robust regulatory frameworks, supporting this market growth. In terms of the U.S. market, it leads primarily with companion animal diagnostics as well as rising awareness in zoonotic diseases.

• Europe

Europe holds a significant market share driven by the stringent animal welfare laws and the increasing government support towards veterinary research. Germany, the UK, and France are major contributors, with significant attention given to livestock health and disease prevention in response to risks from zoonotic diseases and food safety concerns.

• Asia-Pacific

The Asia-Pacific region is witnessing growth due to the rising livestock farming, increased disposable incomes, and increasing adoption of pets in countries like China, India, and Japan. In addition, the government's efforts to prevent animal diseases and ensure food safety are also contributing to the growth of demand for diagnostic kits. However, the health infrastructure and awareness levels differ from one country to another, which creates a challenge.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key enterprise players shaping the animal diagnostic kit market through strategic innovation and market expansion have been introducing advanced diagnostic technologies aimed at improving the accuracy, speed, and convenience of assays for animal health. Strengthening product portfolios with next-generation diagnostic solutions meeting the various demands of veterinary clinics, livestock management, and companion animal care remains a key feature. They are further utilizing digital platforms to enhance market presence, remote diagnostics, and seamless integration with veterinary healthcare systems. These players have been investing in research and development, improving their distribution networks, and exploring untapped regional markets to spur growth and set trends in the animal diagnostic kit industry.

LIST OF TOP ANIMAL DIAGNOSTIC KIT COMPANIES

• Testsealabs – UK
• J&G Biotech – South Korea
• Bionote – South Korea
• Randox Laboratories – UK
• Tianlong Science and Technology – China
• Neogen Corporation Inc – USA
• Microgen Bioproducts – UK
• MEGACOR Diagnostik – Austria
• Illumina – USA
• PortaCheck – USA
• Mercodia – Sweden
• Rapid Labs – UK
• SafePath Laboratories – USA
• Hangzhou Evegen Biotech – China
• Asanpharm – South Korea
• Biovet – Argentina
• Prometheus Bio – USA
• Ring Biotechnology – China
• LifeAssays AB – Sweden
• Eurolyser Diagnostica – Austria
• Affigen – USA
• Biogal – Israel

KEY INDUSTRY DEVELOPMENT

October 2024: IDEXX Laboratories, the animal diagnostic kit market leader, lowered its annual revenue guidance for the third time this year in October 2024. The company said the downward revision was due to a decline in pet clinic visits, which was partly because of inflationary concerns and staff shortages. However, the companion animal group unit reported an increase in revenue in the third quarter.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The animal diagnostic kit market is expected to grow with the increase in awareness of animal health and the prevalence of diseases in both companion animals and livestock. Technological advancements in diagnostic tools, especially point-of-care and molecular diagnostics, are driving this growth. High costs, regulatory challenges, and other barriers do not hinder demand as the need for early disease detection and precise treatment solutions fuels market expansion. The accuracy and accessibility of animal diagnostic tests are significantly improving since industry leaders innovate and expand strategically. In terms of animal diagnostics, future applications and developments will further enhance the market, as early diagnosis and tailored care for animals within veterinary systems will offer greater benefits.